Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Find out what constitutes a good retirement savings strategy. Maximize your contributions and ensure a financially stable retirement.
19,826 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Choosing between the iShares Ethereum Trust ETF and Hashdex Nasdaq Crypto Index ETF comes down to whether you want a ...
Volatile markets push cautious traders toward targeted bets. This piece highlights three ETFs that blend risk control...
Investors have long looked to deals to jumpstart Netflix's growth. Five paraphrased lines from Netflix's co-CEO revea...
Berkshire Hathaway owns a big slice of Apple, and that slice throws off dividend income. This deep dive breaks down w...
A new chapter at Berkshire Hathaway starts with a bold Alphabet bet. This article breaks down why berkshire hathaway'...
A new income-focused ETF blend aims to provide steady monthly cash flow even as markets swing. By splitting $100,000 ...
A single speech by Jensen Huang can tilt markets. This article explains what these words from Jensen might mean for N...
In 2026, the iMGP DBi Managed Futures Strategy ETF (DBMF) is delivering an 11% year-to-date gain against a roughly 5%...
Brent crude has surged aggressively since January, up about 85% by spring. This article breaks down what drove the mo...
A major private markets investor recently exited its position in Paymentus Holdings, shedding a sizable stake in a mo...
JPMorgan's JEPI ETF offers a compelling income stream through covered calls on a diversified 110-name portfolio. This...